Publications by authors named "Harry M Lever"

Claim this Profile
C
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
Christoffer Rasmus Vissing, Anna Axelsson Raja, Sharlene M Day, Mark W Russell, Kenneth Zahka, Harry M Lever

JAMA Cardiol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A data-driven quality-score system for rating drug products and its implications for the health care industry.
Arash Dabestani, Sara Grossman, Joseph P Nathan, Carl W Bazil, Ryan C Costantino, Harry M Lever

J Am Pharm Assoc (2003)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.
Yuri Kim, Mitra Mastali, Jennifer E Van Eyk, E John Orav, Christoffer R Vissing, Harry M Lever

Circ Heart Fail· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of age-sex adjusted NT-proBNP ratio in obstructive hypertrophic cardiomyopathy.
Erika Hutt, Amgad Mentias, Alaa Alashi, Raoul Wadhwa, Agostina Fava, Harry M Lever

Prog Cardiovasc Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel.
Barry J Maron, Joseph A Dearani, Nicholas G Smedira, Hartzell V Schaff, Shuiyun Wang, Harry M Lever

Am J Cardiol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of left atrial strain mechanics on exercise intolerance and need for septal reduction therapy in hypertrophic cardiomyopathy.
Yoshihito Saijo, Erik Van Iterson, Maria Vega Brizneda, Milind Y Desai, Harry M Lever

Eur Heart J Cardiovasc Imaging· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial.
Carolyn Y Ho, Sharlene M Day, Anna Axelsson, Mark W Russell, Kenneth Zahka, Harry M Lever

Nat Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve Replacement.
Milind Y Desai, Alaa Alashi, Zoran B Popovic, Per Wierup, Brian P Griffin, Harry M Lever

J Am Heart Assoc· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Longer-Term Outcomes of Contemporary Patients <18 Years of Age With Hypertrophic Cardiomyopathy.
Alaa Alashi, Laurence Svensson, Jared Klein, Kenneth Zahka, Nicholas G Smedira, Harry M Lever

Am J Cardiol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and Outcomes of Elderly Patients With Hypertrophic Cardiomyopathy.
Alaa Alashi, Nicholas G Smedira, Zoran B Popovic, Agostina Fava, Maran Thamilarasan, Harry M Lever

J Am Heart Assoc· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Guideline-Based Class I Indication Versus Earlier Referral for Surgical Myectomy in Hypertrophic Obstructive Cardiomyopathy.
Alaa Alashi, Nicholas G Smedira, Kevin Hodges, Zoran B Popovic, Maran Thamilarasan, Harry M Lever

J Am Heart Assoc· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LV Global Function Index Provides Incremental Prognostic Value Over LGE and LV GLS in HCM.
Milind Y Desai, Amgad Mentias, Alaa Alashi, Scott D Flamm, Maran Thamilarasan, Harry M Lever

JACC Cardiovasc Imaging· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Physician's Perspective on Generic Drug Quality.
Harry M Lever

J Manag Care Spec Pharm· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Global Longitudinal Strain in Hypertrophic Cardiomyopathy: A Systematic Review of Existing Literature.
Albree Tower-Rader, Divyanshu Mohananey, Andrew To, Harry M Lever, Zoran B Popovic

JACC Cardiovasc Imaging· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different Histopathologic Diagnoses in Patients With Clinically Diagnosed Hypertrophic Cardiomyopathy After Surgical Myectomy.
Alaa Alashi, Ria M Desai, Tamanna Khullar, Kevin Hodges, E Rene Rodriguez, Harry M Lever

Circulation· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of sudden death risk in obstructive hypertrophic cardiomyopathy: Potential for refinement of current criteria.
Milind Y Desai, Nicholas G Smedira, Ashwat Dhillon, Ahmad Masri, Oussama Wazni, Harry M Lever

J Thorac Cardiovasc Surg· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.
Amgad Mentias, Pejman Raeisi-Giglou, Nicholas G Smedira, Ke Feng, Kimi Sato, Harry M Lever

J Am Coll Cardiol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why we need more septal myectomy surgeons: An emerging recognition.
Barry J Maron, Joseph A Dearani, Martin S Maron, Steve R Ommen, Hassan Rastegar, Harry M Lever

J Thorac Cardiovasc Surg· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incremental Prognostic Utility of Left Ventricular Global Longitudinal Strain in Hypertrophic Obstructive Cardiomyopathy Patients and Preserved Left Ventricular Ejection Fraction.
Albree Tower-Rader, Jorge Betancor, Zoran B Popovic, Kimi Sato, Maran Thamilarasan, Harry M Lever

J Am Heart Assoc· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comprehensive Review of Stress Testing in Hypertrophic Cardiomyopathy: Assessment of Functional Capacity, Identification of Prognostic Indicators, and Detection of Coronary Artery Disease.
Albree Tower-Rader, Jorge Betancor, Harry M Lever, Milind Y Desai

J Am Soc Echocardiogr· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Ventricular Septal Measurements in Hypertrophic Cardiomyopathy Patients Who Underwent Surgical Myectomy Using Multimodality Imaging and Implications for Diagnosis and Management.
Dermot Phelan, Brett W Sperry, Paaladinesh Thavendiranathan, Patrick Collier, Zoran B Popović, Harry M Lever

Am J Cardiol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis.
Ahmad Masri, Mohamed Kanj, Maran Thamilarasan, Oussama Wazni, Nicholas G Smedira, Harry M Lever

Cardiovasc Diagn Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
Ashwat Dhillon, Ashish Khanna, Mandeep Singh Randhawa, Jacek Cywinski, Leif Saager, Harry M Lever

Heart· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generics Substitution, Bioequivalence Standards, and International Oversight: Complex Issues Facing the FDA.
Roger Bate, Aparna Mathur, Harry M Lever, Dinesh Thakur, Joe Graedon

Trends Pharmacol Sci· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction.
Barry J Maron, Joseph A Dearani, Steve R Ommen, Martin S Maron, Hartzell V Schaff, Harry M Lever

J Am Coll Cardiol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis